Research and Markets: Monoclonal Antibodies Market for Breast Cancer to More ... Business Wire (press release) The company's latest report* states that this double-digit increase will be driven mainly by the uptake of two recent approvals, Perjeta and Kadcyla, along with the rapid year-on-year growth in specialty pharmaceuticals in the US, which boasts the ... |
